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Abstract
Background: In an effort to better understand the molecular networks that underpin macrophage activation we have 
been assembling a map of relevant pathways. Manual curation of the published literature was carried out in order to 
define the components of these pathways and the interactions between them. This information has been assembled 
into a large integrated directional network and represented graphically using the modified Edinburgh Pathway 
Notation (mEPN) scheme.
Results: The diagram includes detailed views of the toll-like receptor (TLR) pathways, other pathogen recognition 
systems, NF-kappa-B, apoptosis, interferon signalling, MAP-kinase cascades, MHC antigen presentation and 
proteasome assembly, as well as selected views of the transcriptional networks they regulate. The integrated pathway 
includes a total of 496 unique proteins, the complexes formed between them and the processes in which they are 
involved. This produces a network of 2,170 nodes connected by 2,553 edges.
Conclusions: The pathway diagram is a navigable visual aid for displaying a consensus view of the pathway 
information available for these systems. It is also a valuable resource for computational modelling and aid in the 
interpretation of functional genomics data. We envisage that this work will be of value to those interested in 
macrophage biology and also contribute to the ongoing Systems Biology community effort to develop a standard 
notation scheme for the graphical representation of biological pathways.
Background
Macrophages and other antigen presenting cells (APCs)
are present in high numbers in all tissues. They act as a
first line of defence against pathogenic organisms playing
a crucial role in co-coordinating the innate immune
response to infection. Furthermore, it is being increas-
ingly recognized that they not only play a central role in
tissue homeostasis and development, but also in the aeti-
ology and maintenance of pathological processes that
underpin all infectious, inflammatory and malignant dis-
ease [1,2]. Whilst our ability to perform quantitative and
qualitative measurements on the cellular components of
the macrophage has increased massively, as has our
knowledge on how they interact with each other, we have
failed to convert these observations into detailed models
of these systems. However, without such models we can-
not hope to truly understand macrophages or indeed any
other cell at a systems level.
Our primary interest has been to further our under-
standing of the macrophage signalling and effector path-
ways that orchestrate this cell's pivotal role in infectious
and inflammatory disease. As with many systems, certain
macrophage pathways are very well characterized
whereas little is known about many others. Even where
pathway domain knowledge does exist however, it is gen-
erally fragmentary and subjective. Therefore we set out to
generate an integrated model of macrophage pathways of
interest to us and in doing so we have faced one of the
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Page 2 of 18central challenges in pathway biology: How does one con-
struct clear concise pathway diagrams of the known
interactions between cellular components that can be
understood by and useful to a biologist?
Decades of research on the functional activity of indi-
vidual proteins and genes has revealed many insights into
how these cellular components interact with each other
to form the metabolic, signalling and effector effecter
pathways that underpin life. Much of this work however
remains locked inside the literature where specific
insights into pathway function are subject to the semantic
irregularities that come with their description by differ-
ent authors. As a result, the details of a given pathway
have traditionally been known only to a few experts in the
field whose research is often focused on a single protein
and its immediate interaction partners. Pathways are
understood more generally by their description in
reviews and diagrams produced on an ad hoc basis. If we
are to escape this gene-centric view of biological systems,
we must develop better ways to order and display our
knowledge of protein interactions and the systems they
form. Formalized diagrams act as a visual representation
of the interactions between cellular components and pro-
vide a valuable resource for modelling network structure
and the dependencies between components [3]. In addi-
tion, pathway models are an invaluable resource for inter-
preting the results of genomics studies [4-10], for
performing computational modelling of biological pro-
cesses [11-15] and fundamentally important in defining
the limits of our existing knowledge. Large integrated dia-
grams of metabolic pathways have been available for
many years, for example Gerhard Michal's classic bio-
chemical pathways wall chart first published by Boeh-
ringer-Mannheim in 1968. Such pathway diagrams are
inevitably complex, but potentially liberate the user to
explore the interconnectivity between what might be
seen as separate pathways and get an overview of topol-
ogy of the system as a whole. In contrast, the assembly of
detailed diagrams of signalling pathways as integrated
networks rather than a series of disconnected views has
been little explored.
In recognition of the importance of pathways, many
efforts have been made to collate pathway knowledge,
together with information derived from large-scale inter-
action studies and literature mining, into public and com-
mercial databases [16-25]. These offer searchable access
to pathway diagrams and interaction data derived from a
combination of manual and automated (text mining)
extraction of primary literature, reviews and large-scale
molecular interaction studies. Whilst invaluable and in
many ways the best we have, a major problem with these
efforts is that the information content of these diagrams
is frequently limited and visualizations of these systems
are of variable and often poor quality; Pathway compo-
nents are often labelled using inconsistent nomenclature
systems and depicted using a variety of shapes (glyphs) to
illustrate component 'type'. Furthermore, notation
schemes used for pathway diagrams to depict one mole-
cule's interactions with another are not standard and are
often limited in their ability to convey the exact nature of
the relationship between components. Finally, pathway
diagrams are generally highly subjective reflecting the
curator's bias, such that two diagrams depicting the
'same' pathway may share little in common. Together
these factors commonly result in uncertainty as to what
exactly is being shown. The diagrams thereby fail to fulfil
their basic purpose - to provide a comprehensive and
unambiguous picture of what is known about a pathway.
In an effort to address some of these issues, a number of
groups have suggested notation schemes for drawing
'wiring diagrams' of cellular pathways [26-29].
Over the past four years we have been constructing
process diagrams [26] of pathways important in regulat-
ing macrophage immune biology and known to be acti-
vated in these cells during infectious and inflammatory
disease. In constructing these graphical models which
encompass a diverse range of biological pathways and
concepts, we found it necessary to refine the Edinburgh
Pathway Notation (EPN) scheme as previously proposed
[28,30]. The current 'modified' EPN scheme has been
arrived at through extensive use and testing. A specifica-
tion document describing the complete list of mEPN
symbols and rules for their correct use can be found on
http://www.mepn-pathway.org[31]. The macrophage
pathway model presented here, drawn using the mEPN
scheme, explores some of the challenges associated with
meeting the various demands of a pathway diagram. We
hope it will prove to be a useful resource for macrophage
biologists, as well as an important contribution to the
debate on pathway notation and depiction.
Results
The work described here follows in the footsteps of ear-
lier efforts to construct process notation diagrams of
macrophage pathways [30,32]. In the course of the cur-
rent effort we have sort solutions to issues associated
with the depiction of a variety of different biological sys-
tems, combining diagrams from multiple curators and
the layout and integration of a large network model of
these systems. A schematic view of the steps involved in
the assembly of this pathway is shown in Figure 1.
Integrated Pathway Diagram
The pathway diagram presented here (Figure 2 and addi-
tional file 1) is a consensus view of a number of pathway
modules assembled based on our interpretation of the lit-
erature describing these systems. A given interaction
between components of the pathway may be supported
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Figure 1 Pathway construction workflow. A workflow diagram summarizing the main stages of pathway assembly from concept to final diagram. 
Blue boxes portray the pathway construction phase. Each phase embodies a number of tasks (shown as lilac boxes or yellow-ellipses for data storage 
and processing), which when completed lead to progression towards the next stage of pathway construction (connected by green arrows). Red ar-
rows indicate feedback to a previous construction phase. Lilac boxes describe the construction steps required pre-pathway assembly, whereas green 
boxes are linked to post-construction phases and describe the possible applications of the constructed and validated pathway diagram.
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Figure 2 Integrated pathway diagram of innate immune and macrophage activation pathways. The modified Edinburgh Pathway Notation 
(mEPN) scheme is used to describe the interactions of signalling pathways active in the macrophage. A total of 2,172 components in this network are 
connected by 2,553 edges. Components include 496 unique proteins, the complexes formed between them (412), 181 genes/DNA/promotor regions, 
in addition to other molecular species (e.g. pathogens, drugs, RNA) and the nodes representing the processes in which the components are involved. 
Components are arranged to reflect the location in which they are active and background colour is used to distinguish between different sub-cellular 
locations.
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publication may provide evidence supporting more than
one interaction. A total of 1,000 different interactions
have been recorded, supported by 728 different original
papers and reviews (see additional file 2 for a table with
the full list of interactions and supporting publications).
The network diagram is comprised of 2,172 nodes con-
nected by 2,553 edges. The diameter of this network
(maximum distance from one node to another) is 58 and
there is an average node connectivity (number of inputs/
outputs) of 2.37 (max 37). A detailed breakdown of the
class (type) of the nodes that make up the diagram is
shown in Figure 3a. Briefly, 496 unique proteins are rep-
resented in the diagram many of which are shown to go
on to be modified into different forms or bind together
resulting in 412 different complexes. 81 genes are shown
to be transcriptionally regulated by these pathways based
on known associations between transcription factors and
target genes. The interactions between these components
are represented by 552 process nodes, 120 Boolean logic
operators and 158 edge annotations. The pathway is
drawn using the mEPN scheme, a full description of
which can be found on http://www.mepn-pathway.org
and in Freeman et al., 2010 [31] and this and mac-
rophage-related pathways are available through http://
www.macrophages.com.
Description of the Biological Content of the Pathway 
Diagram
The pathway diagram (Figure 2 and additional file 1)
incorporates detailed views of some of the best character-
ized pathways associated with macrophage-specific biol-
ogy, as well as some that are generic, but in some way
linked to the activity of these cells. Figure 3b shows the
approximate location of the different pathway modules
within the diagram. The size of the diagram requires it to
be ideally viewed on a computer. Every effort was made to
arrange modules so those with shared nodes and high
connectivity are located in close proximity, however
given the issues in depicting information on this scale,
'ideal' arrangement of components is challenging. The
interactions between components and limited views of
the pathways they form have been described in detail in
the literature used to construct this diagram (see interac-
tion table, additional file 2). An overview of the pathway
biology depicted by the diagram follows.
Macrophage Pathogen Receptor Systems
Macrophages are equipped with a complex array of pat-
tern recognition receptors (PRRs) that bind a varied
assortment of pathogen-associated ligands. Perhaps the
best studied of these are the membrane-associated toll-
like receptors present on the cell's surface (TLRs 1/2/4/5/
6/10) and lining their endosomal compartments (TLRs 3/
7/8/9) [34,35]. The receptors commonly form complexes
comprised of 6-8 protein subunits which undergo a series
of phosphorylation, dissociation and binding events fol-
lowing engagement of the receptor with their respective
ligand class. As with all such receptor-ligand interactions
shown in the diagram, each successive stage in the forma-
tion and activation of the receptor complex is explicitly
shown (Figure 4a &4b). TLR's are comprised of two func-
tionally significant domains; one for recognizing specific
pathogen associated molecular patterns (PAMPs) and
one for recruiting signalling adaptor proteins following
binding of an appropriate pathogen-derived ligand. The
pathogen recognition domains of different TLR's are
structurally highly variable [36], thereby allowing the rec-
ognition of diverse pathogen-derived molecular species
ranging from viral double- and single-stranded RNA
[37,38] bacterial flagellin [39,40], lipopeptides [41,42],
lipopolysaccharides [43,44], and bacterial and viral CpG
motifs [45,46]. In contrast, the internal domains tend to
be more conserved, reflecting the ability of different
TLR's to recruit the same adaptor proteins; in particular
MYD88, IRAK4, IRAK1, TOLLIP, TIFA, and TRAF6 are
common to most of the TLR receptor complexes. The use
of common adaptor proteins by many of the TLR com-
plexes represented a significant challenge in depiction,
with many edges emanating out of each adaptor mole-
cule. Much effort was therefore put into layout of this sys-
tem so as to provide visual clarity. A comprehensive and
systematic effort to depict TLR signalling has been
reported elsewhere [31] however this was not used in the
construction of the current view of TLR signalling. These
receptors ultimately activate a number of downstream
signalling pathways including the NF-κB, IRF (interferon
regulatory factor) [47] and MAPKinase, ERK, and JNK
signalling [48].
Also represented here are 9 non-TLR cytoplasmic
PRRs, including the NOD (nucleotide-binding oligomer-
ization domain)-Like Receptors and RNA helicases,
whose role it is to detect endogenous stress signals and
intracellular pathogens. NOD-like receptors (NLRs) can
be broadly divided into various classes, the NODS,
NALPS and other types of NLRs, based on their protein
domain structures. Bacterial associated PAMPs (e.g.
flagellin and various classes of peptidoglycans) are recog-
nised by NOD1, NOD2 and NLRC4 (IPAF1) which acti-
vate the NF-κB and MAPKinase pathways. NOD1 can
also lead to the cleavage of IL1B into its active form. The
NALPS (NLRP1, NLRP2, and NLRP3) detect a range of
stress signals such as K+ efflux, DNA, ATP or membrane
damage, often collectively referred to as danger-associ-
ated molecular patterns (DAMPs). Once activated by
DAMPs the receptors form oligomers with inflammatory
caspases (CASP1/5) and in doing so activate the cleavage
of the caspases [49]. The active complexes are known as
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vate interleukin proteins, and are crucial mediators of the
inflammatory response. Although three NALP receptors
have been depicted up to 14 different NALPS have been
reported [50,51]. Finally, RNA helicases are responsible
for the intracellular recognition of viral single stranded
and double stranded RNA. The diagram shows DDX58
(RIG-1) and IFIH1 (MDA5) which recruit factors via
their CARD domains and eventually initiate anti-viral
gene expression by activation of the NF-κB system. The
ZBP1 protein was recently characterized as a sensor of
viral DNA [52] and activates the IRF3 transcriptional
pathway. As such the PRR systems depicted represent a
comprehensive view of these receptors and the signalling
pathways they activate. However the diagram still lacks
other known macrophage PRRs, including the surface
mannose receptor, secreted receptors e.g. those belong-
ing to the complement system and the recently described
DNA receptor AIM2 [53-56].
Figure 3 (a) Breakdown of node class in the integrated pathway diagram and (b) Key to the pathway layout and content of the integrated 
diagram. (a) Components, Boolean Logic, Process Nodes and Edge Annotation form the category of possible nodes. A detailed breakdown of the 
number of each type of node in each category is given. (b) The key reflects the approximate location of the different pathway modules depicted in 
the integrated diagram (Figure 2). Ideally pathways with high connectivity and sharing identical components are spatially located in close proximity.
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Figure 4 Snapshots from the integrated macrophage pathway diagram. (a) Activation of the interferon type-1 receptor through its inter-
action with interferon-α (IFNA) or interferon-β (IFNB1). In each case binding of the ligand causes autophosphorylation of JAK1 which eventually 
leads to the type1-interferon response (not shown). (b) Activation of TLR7 by single stranded RNA in the endosome. This sequential multistep 
process involves binding events, autophosphorylations and dissociations steps. (c) E3 ligase system. Up to 500 proteins may potentially function as 
E3 ligases and here the well documented members are shown. (d) Depiction of the proteasome. In some cases it is useful to lay out the subunits 
of a complex to reflect the complexes known structure. Represented here are the layers of the proteasome's barrel structure and cap. (e) Activation 
of MAPK14 (p38). Phosphorylation of p38 is reversible; numerous kinases will phosphorylate p38. p38 is dephosphorylated by DUSP1 and inhibited 
by the specific inhibitor SB203580. (f) Combinatorial assembly of the MHC class 2 HLA-D (alpha/beta) complexes. The & and OR Boolean opera-
tors indicate the combinatorial assembly of HLA-D (alpha/beta) complex from different classes of MHC class 2 proteins. (g) Genes activated by 
NFKB1 (p50):RELA (p65) complex. A number of genes activated by the binding of the p50:p65 complex to known NFKB elements in their promoter. 
In each case the likely functional consequence of this activation is shown as a pathway output. (h) Regulation of IFNB1 expression. Shown are the 
known promoter elements and factors that bind to them leading to IFNB1 expression.
a b
c d
e f
g h
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Page 8 of 18Cytokine Activation Pathways
The diagram also describes a number of the main
cytokine signalling systems active in macrophages. These
include the interferon (type 1 - IFNA/IFNB and type 2
IFNG), interleukin 1B (IL1B), TNF, TNFSF10 (TRAIL),
TNFSF13B, FASLG and CD40LG signalling pathways. In
each case these have been depicted starting from their
interaction with their receptor complexes (Figure 4a)
through to the activation of their downstream signalling
and effector pathways. Interestingly, the expression of a
number of these ligands is activated by PRR pathways
(e.g. IL1B, IFNB) producing autocrine feed-forward
loops. IFNB is perhaps one of the best studied genes in
the whole genome in terms of its transcriptional regula-
tion [35,57-59]. It is also one of the primary targets for a
number of the macrophage PRR activation pathways
described above and we therefore constructed a detailed
model of its regulation (Figure 4h). Part of the reason
behind this was also to grapple with the issues with
depicting transcriptional networks and we believe the
solution arrived at should work for other systems. In the
current diagram however, we have generally chosen not
to depict the links between cytokine gene activation (or
indeed between other genes) and their respective pro-
teins (via translation). The depiction of these edges adds
to the visual complexity to the diagram. For modelling
purposes however these connections can be added.
Apoptosis (Programmed cell death)
A potential output of the innate immune response is to
culminate in host cell suicide (apoptosis) thereby poten-
tially limiting further reproduction of pathogenic organ-
isms such as viruses. Two major routes of apoptosis
execution have been identified, termed the intrinsic and
extrinsic pathways. The intrinsic pathway is activated as a
result of stress signals detected within the cell, for exam-
ple, penetration of a viral pathogen into the cell or UV
light induced DNA damage. Extrinsic apoptosis on the
other hand is triggered by extracellular death-signalling
ligands (FAS, TNFSF10 (TRAIL), TNF which are also
members of the cytokine activation pathways) binding to
the cell membrane receptors. Both intrinsic and extrinsic
pathways activate a number of the caspase family of
cysteine proteases. The initial caspases to be activated are
categorized as initiators, (CASP2/4/6/8/9/10) and are
capable of cleaving downstream executioner caspases,
specifically CASP3 and CASP7. Caspases 3 and 7 initiate
the series of events that directly lead to the morphologi-
cal changes in a cell associated with apoptosis by the
cleavage or inactivation of an array of molecules includ-
ing, structural proteins, DNA repair proteins, and anti-
apoptotic proteins.
Signal Transduction and Transcription Factor Networks
The NF-κB (nuclear factor kappa-light-chain-enhancer of
activated B cells) family of transcription factors are piv-
otal in the regulation of a wide variety of biological pro-
cesses [60-63]. This includes many aspects of the innate
and adaptive immune response, as well as the regulation
of a diverse range of stress-related stimuli [64]. 5 different
NF-κB proteins (REL (c-Rel), RELB (REL), RELA (p65),
NFKB2 (p100 or p52), NFKB1 (p105 or p50) have been
identified and these form a variety of homo- or hetero-
dimers resulting in an array of different NF-κB com-
plexes. Previously [30] we described the activation of two
of the best-characterized NF-κB dimers; NFKB1:RELA
(also known as p50-p65) and NFKB2 (p52):RELB, often
referred to as the canonical and non-canonical pathways,
respectively. However, we soon realized that this diagram
was a rather naïve view of the NF-κB system and we set
out to explore the literature on this system in greater
detail. These efforts have resulted in our depiction of 14
different NF-κB dimers formed from combinations of the
five NF-κB proteins. In addition to the 14 dimers, some
NF-κB complexes form further complexes with a number
of accessory proteins (NFKBIA/B/E/Z, BCL3, HMGA1,
CREBBP, HDAC3, NCOR2) and together with their regu-
lation by multiple phosphorylation events, give great
diversity in the form and control of this important class of
transcription factors. This goes someway to explaining
the pleiotropic effects regulated by this system [65]. It is
unlikely however that all the possible NF-κB systems
depicted are active in the macrophage or indeed any
other single cell type. NF-κB signalling is often cited in
loose terms in literature with little reference to the exact
NF-κB complex active in any given situation. The path-
way diagram presented here demonstrates the complexity
of this system and underscores the need for acknowledg-
ing the range of possibilities beyond the canonical and
non-canonical NF-κB pathways.
As mentioned above, phosphorylation is a key element
in the activation process of many of the NF-κB com-
plexes. In the pathway, dimers of the core proteins may
bind to NFKBIA, NFKBIB or NFKBIE, a group of I-
kappa-B or NF-κB inhibitor proteins. When bound to
their inhibitor, the NF-κB complexes are restricted to the
cytoplasm. Upon stimulation the I-kappa-B proteins are
phosphorylated, leading to their ubiquitination and even-
tual degradation, and the release of the active NF-κB
complex. Dissociation of the inhibitors exposes the
nuclear localization domain on the NF-κB complex caus-
ing it to translocate to the nucleus where it can modulate
transcriptional activity of target genes [66,67]. Other NF-
κB complexes (which are not bound to inhibitors) are
activated following cleavage into smaller DNA-binding
subunits. This is induced by stimuli phosphorylating the
complex leading to its ubiquitination and subsequent
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DNA binding peptides e.g. NFKB2 is processed from
p100 to p52. Currently there are 34 genes shown on the
diagram as the transcriptional targets of NF-κB signalling
(Figure 4g). In reality this is only a small percentage of the
known NF-κB targets [68]. Furthermore, the representa-
tion of the transcriptional regulation of these genes is
almost certainly a gross over simplification, as there are
likely to be other transcription factors acting in concert
with NF-κB to modulate gene expression.
The pathway diagram presented here also includes pre-
liminary views of some of the kinase signalling pathways
known to be associated with macrophage activation.
These include the MAP2K1/2 (MEK1/2)-MAPK3/1
(ERK1/2) cascade known to be activated by TLR signal-
ling and the MAPK8 (JNK)-JUN (AP1) and MAPK14
(p38) (Figure 4e) cascades activated by NOD1/2 and TLR
signalling. These pathways are clearly important to mac-
rophage activation and are known to influence a range of
different processes such as cell differentiation, cell cycle,
phagocytosis and apoptosis. However, due to their appar-
ent parallel and overlapping functions and their involve-
ment with so many cellular processes, a precise
understanding of their relative contributions to mac-
rophage biology is unclear.
Antigen Presentation and Related Pathways
Antigen presentation is not exclusive to macrophage biol-
ogy but equally central to it. We have attempted to depict
the MHC class I and II pathways from either the degrada-
tion of cellular proteins or the phagocytosis of pathogens,
to the presentation of cellular/pathogen peptide antigens
to CD8 cytotoxic T-cells or CD4 T-helper cells, respec-
tively. In order to achieve this however, we found it neces-
sary to construct diagrams of the ubiquitination pathway
(due to it role in tagging cellular and pathogen proteins
with ubiquitin) and proteasome formation (due to the
role of the proteasome in the digestion and/or processing
of ubiquitinated proteins). These latter two systems are
also crucial to many aspects of cell biology, being respon-
sible for the activation and/or degradation of many cellu-
lar and pathogen proteins alike. Depiction of these
systems proved to be challenging. In the first instance,
whilst our view of phagocytosis is greatly simplified, we
had to find ways to show the passage of key molecules in
the antigen presentation pathways from their assembly in
the endoplasmic reticulum (Figure 4f) to their transport
to the phagosome via the golgi and intermediate endo-
somal compartments. This required us to show events
both at the molecular level, as well as the transition of
compartments in which they reside from one state to
another. In this case nodes representing pathway modules
have been used to link one compartment to another indi-
cating a series of vesicular transitions and fusions; com-
plex processes in their own right. Another challenge was
the depiction of the ubiquitination pathway. In short, pro-
teins are tagged for degradation or cleavage through their
binding to E3 ligases. Each E3 ligase or E3 ligase complex
binds specific protein targets. We have shown a number
of classes of these molecules i.e. the HERC/HECT, ring
finger, U-box and SCF E3 ligases, encompassing over 80
proteins in total (Figure 4c). However many more pro-
teins are thought to be associated with this role, perhaps
as many as 500 [69,70]. To add to this complexity there
are 36 known E2 ligases and 6 E1 ligases which add fur-
ther specificity to this system. Clearly it would be impos-
sible to show each individual protein and their associated
E3 ligase passing through the ubiquitin pathway (even if
the details were known) and therefore it has been
depicted as a generic process; proteins bind E3 ligases,
which provide a scaffold for ubiquitin transfer from E2
ligases, resulting in the ubiquitinated-protein being pre-
sented subsequently to the proteasome for processing.
When a protein in the pathway is ubiquitinated we show
this using a process node with the symbol Ub, which is
essentially a short cut to showing this process. In our
original pathway [30] we depicted the proteasome as a
single node responsible for the cleavage and activation of
ubiquitinated NF-κB complexes. As we looked further
into the nature of the proteasome however, we began to
appreciate that there is not just a single proteasome but at
least 5 specific proteasome complexes; the 26S, 11S
capped and 19S+11S capped hybrid constitutive protea-
somes, and 11S and 19S+11S capped hybrid immunopro-
teasomes [71,72]. In an effort to show something of the
structure of these large barrel-like complexes, we chose to
depict the layered arrangement of core subunits into four
stacked rings (7 subunits per ring/layer), where appropri-
ate capped with other subunits that form the regulatory
particles (Figure 4d). By linking the proteasomes with the
generic model of the ubiquitination pathway we have also
attempted to show each proteasome's preference for the
cleavage of a specific class of peptides. However in doing
this, it is not possible to show whether the given output of
a proteins ubiquitination and cleavage is an activated
peptide, a peptide for antigen presentation or the com-
plete destruction of the protein. Where a protein in a
pathway is degraded we have used the sink glyph (Ø) as a
short cut to indicate that the protein has been removed
from the system by proteasomal degradation.
Compatibility of mEPN Pathways with Other Pathway 
Analysis Tools
The pathway model presented here is primarily designed
to function as a computation resource. Its size as well as
the fact that additional information is available through
mouse-over or hyper-linked from it, means that it is best
viewed on a computer. The diagram has been constructed
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(yFiles software, Tubingen, Germany), a general purpose
tool designed for the depiction of network-based dia-
grams. The standard file format used with this program is
.graphml which is also supported by other network/path-
way editors [73-76]. In this format pathways are available
for editing and expansion or alternatively using the yEd
editor, can be exported from the program in a number of
image (.jpeg, .png, .pdf ) and exchange formats (.tgf, .gml,
.ygf, .xml, .html). The pathway is also provided as .pdf and
.html formats (additional files 3 &4). In order to enhance
options for the display, analysis and integration of these
pathways with other data types we have recently imple-
mented the import of .graphml files into Biolayout
Express3D, a network analysis tool co-developed by our
group [76,77]. This program supports a range of other
network analysis features and is suited for working with
small or large networks derived from other data sources.
A 'layout' file has been provided (additional file 5) such
that the diagram can be viewed in this tool as either a
conventional 2D or 3D network diagram, in both cases
using the node co-ordinates from the .graphml file
(although polylines are not supported). Alternatively the
diagram can be viewed in 3D using a modified Fructer-
man-Rheingold organic layout algorithm [78]. A notation
system consisting of 3-D shapes is applied in the 3-D view
of the pathway [31] (also see http://www.mepn-path-
way.org). With the ever increasing amounts of interaction
data it becomes more evident that an extra dimension
will be valuable for the visualisation of large pathways and
eventually an in silico cell. The BioLayout Express3D inter-
face also supports the follow through of connectivity in
pathways such that the parent or children nodes of a
given selection can be highlighted and selected nodes
hidden or isolated.
Pathway diagrams are frequently used as an aid to the
interpretation of experimental data e.g. gene expression
analyses, proteomics screens whereby the results of these
studies are be overlaid on top of pathways to provide con-
text to the findings. To facilitate these analyses we have
recently implemented an "import class-sets" functionality
into Biolayout Express3D, allowing lists of genes of inter-
est and/or annotations to be easily exported directly from
the tool and identified on the pathway. Figure 5 and addi-
tional file 6 demonstrate the use of the "import class-set"
function to highlight pathway components regulated in
response to a timecourse of Ifn-β treatment of mouse
bone marrow derived macrophages (GEO accession
GSE20403). Lists of co-ordinately expressed transcripts
from the mouse expression analysis were saved as a class-
set file and imported onto the 'human' macrophage path-
way diagram using the tool. This approach allows the
rapid visualization and identification of those pathway
components that are regulated by Ifn-β. 95 pathway com-
ponents matched Ifn-β regulated transcripts, 77 were
present in clusters representing up-regulated genes and
18 were present in down-regulated gene clusters. Addi-
tional file 6 provides the BioLayout Express3D file of the
macrophage pathway with the regulated genes enlarged
and coloured according to their cluster membership. The
pathway was inspected for regions of regulated compo-
nents and some of the interesting observations are shown
in Figure 5.
In the ways described above, the diagram presented
here represents a detailed consensus view of a range of
pathway systems that are of interest to and the subject of
ongoing research into macrophage biology. It has been
designed to be easily accessible, distributable and can be
modified by end users to suit their interests or knowl-
edge-base. Finally, we continue to develop software to
facilitate the use of such resources for pathway modelling
and interpretation of genomics data.
Discussion
Interest in 'pathway biology' has never been greater as we
struggle to comprehend cellular systems from a combina-
tion of targeted studies and the deluge of data flowing
from 'omics platforms. This is reflected by the escalating
efforts to assemble pathway diagrams [30,32,33,79,80],
develop standards for depicting pathways [26-28,81],
software to support their construction [82-84] and
exchange [85-87], and the development of approaches to
model and predict pathway behaviour [13,88,89]. Whilst
arguably there is no such thing as a pathway only one big
integrated network of molecular interactions, it is still
useful to think in terms of pathways as being connected
modules of this network. As such a pathway may be con-
sidered to consist of a specific biological input or event
that initiates a series of directional interactions between
the components of a system leading to an appropriate
shift in cellular activity. As we begin to appreciate the
potential complexity of these molecular networks, there
is increasing interest in modelling pathways in order to
expand our understanding of biology from the traditional
gene-centric view of life, to a systems level appreciation
of biological function.
The pathways described here are of central importance
to understanding macrophage biology and therefore
innate immunity, and the diagram provides a consensus
view of these systems. This is not to say that the model is
either viewed as complete or necessarily even correct, but
only as a working model. As such it has been designed
with the idea that it will need to be modified and
expanded based on new publications, experimental
observations or deeper insight into specific systems. All
of the pathways depicted are reasonably well character-
ized and as such there is a relative abundance of informa-
tion on them from a wide variety of sources. What we
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Figure 5 Overlay of Ifn-β timecourse analysis onto the macrophage pathway using BioLayout Express3D. Views of regions of the macrophage 
pathway where components were found to be regulated Ifn-β. Components regulated at the level of gene expression are enlarged and coloured 
according to their cluster membership. All non-regulated components and other nodes are grey. (a) Regulation of Toll Like Receptor Signalling. 
All endosomal TLRs, Myd88 and Tifa genes are induced from 1 h, their expression being maximally up-regulated at 4-8 h post-Ifn-β treatment. (b) Reg-
ulation of death-receptor and apoptosis signalling. The expression of all regulated components in this module rises from 1 h and reaches a max-
imum 2-4 h post-treatment. In contrast, the expression of the anti-apoptotic gene Bcl2 is suppressed at 4 h. (c) Regulation of the transcriptional 
targets of interferon signalling. 7 genes (shown in yellow) belong to cluster 2 and their expression induced from 1 h, becoming maximal at 4 h. 4 
genes (in purple) were in cluster 3, with expression rising from 1 h and remaining maximal throughout 4-8 h post-treatment. Irf1 (in green) reaches 
maximal expression at 2 h. (d) Regulation of type I and type II interferon signalling. All receptor components, except Ifngr1, belong to clusters of 
induced genes. Socs1 and Socs3 are induced and reach maximal expression at early time points (1-2 or 2 h).
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understanding of these pathways and integrating this
view with the abundance of data generated on these cells
by ourselves and others. Our aim has therefore been the
creation of a pathway diagram that graphically reflects
the current view of a pathway system in a visibly intuitive
manner. In so doing we wished to create a resource for
data integration, pathway modelling and hypothesis gen-
eration. In order to achieve these objectives we found it
necessary to modify both the PDN [26] and EPN schemes
[28] for pathway depiction. Our original diagram [30]
acted as our framework for the current effort helping to
highlight the many gaps in our understanding and
together with developing interests in macrophage biol-
ogy, helped to prioritize areas for future modelling. Mod-
elling of the pathways continued to be based on labour-
intensive curation of the literature. Post-graduate stu-
dents were given an area of biology to examine, and all
the resources for researching the literature and depicting
their chosen pathway module. Regular debates on the
progress of the pathway models were held, and through
this process deficiencies were plugged in the graphical
depiction of events, pathway content, notation, compo-
nent labelling and the recording of the supporting infor-
mation; a process which in itself was highly informative.
An important point is that the diagrams can be shared
and understood by all those familiar with notation, and as
a result all the work presented here has been subjected to
form of internal critiquing. However, each new area of
biology included in the current diagram has presented its
own problems in layout and concept representation. As a
result there has been subtle but almost constant re-evalu-
ation of various aspects of the notation scheme and as we
have dealt with new issues in the depiction of different
systems. We are now satisfied that mEPN scheme has
matured to the point where we foresee little need to
change the majority of the notation scheme presented
here (see Freeman et al., 2010 [31] and http://www.mepn-
pathway.org), although clearly the modelling of other sys-
tems and ideas from others may present a case for further
modifications.
Pathway diagrams are a well established tool in our
effort to interpret and explain results from functional
genomics investigations. Overlay of results, usually from
studies of the difference between one biological state and
another, on top of pathway diagrams allows the investiga-
tor to visualize and link observations to defined path-
ways. BioLayout Express3D, a network analysis tool
developed by us, provides a powerful approach to visual-
ize and analyze 'omics data from a variety of sources [77].
We have recently implemented the import of .graphml
files into BioLayout Express3D and the tool now supports
the visualization of pathway diagrams as 3D or 2D net-
works [76]. A parser automatically converts the mEPN
notation into the equivalent 3D notation scheme and can
use the diagrams original node co-ordinates to layout the
pathway. We have now also implemented the ability to
export analyses from one dataset e.g. clustering of
microarray gene expression data and import and overlay
these analyses on to another network. As we have used
standard gene nomenclature in the assembly of this path-
way it is possible to map directly between gene identifiers
from data to genes/proteins in the pathway. Analysis of
the transcriptional response of mouse bone marrow
derived macrophages (BMDM) to Ifn-β stimulation has
been used here as an example (Figure 5 and additional file
5). In practice any number of lists with annotations can
be imported as class-sets onto the pathway and one can
envisage how this would facilitate the comparison of
numerous data sets in the context of the macrophage
pathway. Although the concept of data mapping onto
pathways is not new and is supported by other pathway
resources [6,19,90] these pathways suffer from a number
of issues pertaining to the lack standard graphical nota-
tion used to depict them. Furthermore the nature of the
pathway presented here (in terms of scale, detail, forma-
lised notation, range of pathways covered and integrated
nature of their presentation) presents a valuable addi-
tional resource for those interested in macrophage biol-
ogy or any of the pathways covered. Clearly the better and
more extensive the pathway diagrams are the easier it will
be to provide a working hypothesis on the interpretation
of data. Increasingly, it is now experimental data that is
helping to refine existing pathway models and observa-
tions that we do not understand that are driving our cur-
rent modelling efforts.
As a note of interest on pathway topology, it has been
suggested that many metabolic and signalling pathways,
such as the TLR system, possess a 'bow-tie' or 'hourglass'
structure [31,80,91-93]. This is to say that the results
from these modelling efforts where pathways are
depicted using other notation systems or depicted based
only on protein-protein interactions [94], suggest that
many signalling pathways possess structures where
numerous inputs (ligand/receptor interactions) feed
through a small number of 'hub' adaptor molecules to
give rise to large and overlapping responses. In this view
of signalling pathways proteins common to numerous dif-
ferent signalling systems e.g. MYD88 in the TLR system,
are generally viewed as more important than other com-
ponents in ensuring a network's robustness to perturba-
tion due to their high degree of connectivity. Our model
of the TLR system would also support the idea that many
of the TLR's all signal through use of a limited number of
proteins e.g. MYD88, IRAK4, TIFA, TRAF6, TOLLIP. In
each case these proteins act as members of receptor-
adaptor complexes propagating the signal induced by
ligand binding. In the case of each TLR, the model sug-
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on a number of MAP3K7 complexes which subsequently
go on to activate IKK complex and ultimately NF-κB
transcription factors. However, there is also clear evi-
dence linking TLR signalling to the activation of
MAPK14 (p38) and MAPK1/3 (ERK) cascades [95,96].
The literature would also suggest that engagement of
endosomal TLRs and the MYD88-dependent TLR4 path-
way leads to an activation of IFNB expression via IRF3
[97,98]. Hence the TLR system acts through numerous
signalling networks to bring about the extensive tran-
scriptional changes that are associated with immune acti-
vation by LPS or other TLR ligands. The signalling
systems used by TLRs are also used by other receptors.
For example, the activation of IFNB expression via IRF3 is
also utilized by ZBP1, DDX58 (RIG-I) and IFIH1 (MDA5)
cytosolic DNA/RNA receptors [52,99-101]. Activation of
IFNB undoubtedly contributes to the transcriptional sig-
nature observed when these systems are activated. Fur-
ther complexity still is evident if we consider that these or
indeed other immune responses are all clearly modulated
by feedback control [102]. Indeed, a number of negative
regulators are observed to be some of the earliest up-reg-
ulated genes in the type 1 interferon response measured
here e.g. Socs1/3, Prdm1, Nfkbiz. At the same time many
feed-forward loops are being established by the up-regu-
lation of transcriptional regulators which go on to acti-
vate genes associated with effector systems/pathway
modules. Our integrated model of macrophage signalling
pathways would therefore suggest extensive cross-talk
between pathway modules and transcriptional networks
with a high degree of feedback and feed-forward control
taking place. It would also predict that many proteins/
genes contribute to the networks functional activity and
robustness. This is born out by the fact that pathogens
are known target many different molecules in their effort
to evade or subvert the immune response [103,104], and
polymorphisms in numerous proteins has also been
shown to be implicated in susceptibility to infectious and
inflammatory disease [105-108]. Furthermore, experi-
mental modulation of these systems suggests that their
activity is directly regulated by numerous factors acting at
different levels [109]. Therefore how real or useful the
concept of a bow-tie structure is for such pathways espe-
cially with respect understanding their robustness is
highly questionable. Indeed the network of molecular
interactions that make up the immune system is clearly
highly susceptible to perturbation by numerous factors
acting at different levels within the network architecture.
It has evolved through constant challenges by a diverse
range of pathogens. Its robustness relies on the fact that
on a population scale its response in different individuals
is varied such that what in one may kill, in another may be
tolerated.
The task of assembling this diagram has been time con-
suming and laborious involving 1,000's of hours of work.
On the other hand, it summarizes the results of investiga-
tions that have taken many times that amount of time to
perform and it is difficult to envisage how one could préc-
is this body of work in any other meaningful way. To gain
a systems level view of these pathways is to gain an
insight into the molecular networks that regulate normal
immune function and whose malfunction or manipula-
tion underpins inflammatory and infectious disease.
Greater understanding of the overall architecture of the
immune system and its susceptibility to deregulation by
pathogens and other disease causing agents, should ulti-
mately lead to new strategies and targets for therapeutic
intervention. Apart from summarizing decades of
research, pathways depicted with formalized graphical
notation schemes should aid the communication and
comparison of biological data. During a thorough process
of internal critiquing sections of the pathway were pre-
sented to others who were familiar with the notation
scheme but not involved in constructing the pathway pre-
sented to them and asked to interpret the biology shown.
This process ensured that the interactions of the pathway
were not ambiguous in their depiction. Another major
incentive for generating pathways with standard nota-
tions is to permit the conversion of graphical models into
computationally tractable ones, suitable for analysis and
simulation. For this purpose we have been exploring the
use of signalling Petri nets (SPN) [89] for modelling
"flow" in the integrated pathway diagram. The approach
is suited to large scale models and the mEPN scheme
used to construct the pathway is easily adaptable into a
SPN.
For us the exercise of pathway construction has pro-
vided a resource for training, pathway modelling, litera-
ture/data interpretation, hypothesis generation and as
such is now central to our ongoing investigations of mac-
rophage biology. Importantly however, the pathway
model presented here also serves as a worked example of
how pathways might be represented in a logical, unam-
biguous and biologist-friendly fashion, whatever the sys-
tem of interest. What we would like to see and believe is
essential, is the support of the wider community in
assembling and editing such diagrams. Such efforts are
already underway [22-24] and are already providing a
vital forum for debate on the known details of pathways
in different cell systems. Ideally these efforts will result in
detailed models of biological systems that can be shared
and assimilated. However, in order to achieve this end
pathway models clearly need to be assembled using stan-
dard rules and graphical languages. We therefore hope
this work will contribute to the ongoing community
effort to develop such standards [29].
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The formalised depiction of biological pathways is
increasingly recognised as a crucial requirement for the
exchange of pathway data, modelling of their activity and
systems level interpretation of biological data. However,
there are just a handful of worked examples of large path-
way diagrams constructed using a formalised graphical
modelling language. The model of macrophage signalling
and effector pathways presented here is to our knowledge
the most comprehensive pathway of its kind published to
date. As such it offers a worked example of how large
pathway and has also proved to be a testing ground for
the mEPN system [31]. When presented in this manner
the network reflects the extensive cross-talk between
pathway modules and transcriptional networks and high
degree of feedback and feed-forward control taking place.
This topology does not support the reported bow-tie
structure that has been inferred from other pathway
modelling efforts.
Although a time consuming and laborious exercise, the
act of converting literature derived knowledge into a for-
malised computational models is essential if we wish to
truly gain a systems level understanding of any cellular
system. The macrophage model presented here summa-
rizes the results of years of investigations and has allowed
the thorough testing of the notation system used to
depict it. The hope is that this work will provide a useful
resource for others interested in the macrophage and the
pathways depicted, and will help contribute to the devel-
opment of standard graphical depiction in biology.
Methods
Data mining, curation and organization
Ongoing analysis of macrophage-related datasets and an
interest in consolidating our knowledge of a number of
signalling pathways directed our choice of pathways to be
mapped (see Figure 1). Public and propriety databases
were initially used as resources for data mining, but ulti-
mately all molecular interaction data was sourced from
published literature. Manual curation of the literature
was performed to firstly evaluate the quality of the evi-
dence supporting an interaction and secondly, to extract
the necessary and additional pieces of information
required to 'understand' the pathway and construct an
interaction diagram. We have drawn pathways based on
our desire to model pathways active in a human mac-
rophage and therefore all components have been
depicted using standard human gene nomenclature
(HGNC). However, our understanding of the pathway
components and the interactions between them, have
been drawn largely from a consensus view of literature
knowledge. As such the pathways presented here are
based on data derived from a range of different cellular
systems and mammalian species (human and mouse).
The following details were captured in an interaction list
spreadsheet: PubMed ID (of the paper citing the interac-
tion); the names and official HUGO and Entrez IDs of the
interacting components; the nature of the interaction
(additional file 2).
Pathway construction
Individual pathway diagrams focused on a specific area of
biology were constructed by teams of 1 or 2 curators who
were given a remit to describe a given pathway system
using the mEPN scheme [31], generally over a 3-6 month
period. Primary curators were junior biologists (MSc stu-
dents) who were encouraged to use all information
resources available to first build up an overall picture of
these pathways prior to more detailed analyses and litera-
ture-based verification of interactions. Great emphasis
was also placed on group work and the need to discuss
and justify the information they were attempting to rep-
resent to others. Layout was assessed by several curators,
as was pathway content and notation usage. Essentially,
we attempted to ensure that the graphical depiction of
pathway/interactions was intelligible and unambiguous
to another individual familiar with the notation scheme.
Teams of curators were therefore encouraged to show
and discuss their progress with other members of the
group on a regular basis.
All pathways have been constructed as directional net-
works. Interactions between pathway components are
drawn using the principles laid down by the mEPN
scheme [31] and diagrams assembled according to the
workflow described in Figure 1. The current mEPN
scheme and a detailed description of the notation scheme
and rules for its use are provided in Freeman et al., 2010,
[31] and http://www.mepn-pathway.org. Individual path-
way maps were drawn using the freely available program
yEd graph editor (yFiles software, Tubingen, Germany)
and later the pathways were integrated using the same
software. In order to make these diagrams an informa-
tion-rich vehicle for conveying details about pathway
components and the reactions between them, PubMed
IDs supporting the interactions are stored on appropriate
edges or nodes within the .graphml version of the dia-
gram, as are URL-links to Entrez gene for each protein or
gene component in the pathway and notes from the cura-
tors. Due to the nature of pathway construction edges are
often moved, deleted then redrawn to optimise the path-
way layout and for this reason annotation may also be
linked to an appropriate process and/or edge annotation
node.
Pathway Optimization and Integration
Following an initial development period, the focused dia-
grams went through extensive editing in attempt to unify
their notation usage, stylistic qualities and overall appear-
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text font, text size, edge thickness etc.) were standardized
between the diagrams. The original pathway diagram [30]
was then used as a framework on to which new pathways
were 'bolted'. A central rule of the mEPN is that a particu-
lar component in a given state may only be represented
once in any sub-cellular compartment [28,30,31] Thus
when integrating the diagrams a crucial step was to iden-
tify, using the interaction and component lists, overlap
between pathway members in the individual diagrams.
Connections could then be built between the individual
pathways based on shared pathway members and com-
mon interactions. For example, a number of the systems
of interest feed into the NF-кB system including the TLR
and non-TLR pathogen detection receptor signalling,
TNF-receptor activation, apoptosis and MAPKinase sig-
nalling. If the representation of interactions differed
between individual diagrams they were re-examined by
going back to the literature. Furthermore, annotations
and curators notes were moved and preliminary layouts
optimized. Depicting this interconnectivity ultimately
leads to numerous challenges in arranging the layout of
the diagram. This was particularly acute when laying out
the integrated diagram. A significant leap forward was
made with the realization that however 'optimized' the
layout of the diagram it was too large to be displayed in a
readable format on a single page (as had always been the
aim when working on a smaller scale when trying to pro-
duce a 'publication ready' layout). With this in mind we
could be more free with our use of space and in the final
layout, pathway 'modules' consisting of numbers of con-
nected nodes involved in a similar system are separated
out. This has the effect that more space is available to run
tracks of parallel edges between modules and subsequent
additions or editing are easier to perform. Following the
integration of TLR system with the original diagram, the
NF-κB, non-TLR and proteosome maps were added
sequentially according to the same principles. The fully
integrated map then underwent an extensive series of lay-
out optimizations in order to bring visual clarity to final
product.
Pathway Overlay of the Transcriptional Response Analysis 
of Mouse Bone Marrow Derived Macrophages to Interferon 
beta Treatment
Analysis of a timecourse of interferon-beta (Ifn-β) treat-
ment of mouse bone marrow derived macrophages
(BMDMs) was used as an example of data integration
onto the macrophage signalling pathway using BioLayout
Express3D. Mouse BMDM preparation, cell culture, and
cytokine (Ifn-β) treatment was performed as described in
the data sets GEO submission; accession no GSE20403.
Expression data (available at GEO, accession GSE20403)
was normalized using the RMA package within the
Affymetrix Expression Console software and annotated.
Transcripts which might be considered to be differen-
tially expressed at each time point compared to 0 h were
identified using the Empirical Bayes function within the
Bioconductor [110] package of the R statistical program
using a 1.5 fold cut-off and a p-value of 0.05. According to
this analysis 2,300 transcripts were considered to be dif-
ferentially expressed. Data corresponding to these tran-
scripts was then loaded into the network visualization
tool BioLayout Express3D [76,77] using a Pearson correla-
tion cut-off of 0.9 to filter edges. The resultant network
graph of 2,045 nodes (connected by 92,947 edges) was
clustered using the graph-based clustering algorithm
MCL [111] set at an inflation value of 2.2 resulting in 33
clusters (with greater than 5 nodes). Manual inspection of
the clusters revealed 21 clusters of interest i.e. their
expression profile was consistent with the genes being
regulated by Ifn-β. Resulting clusters represent patterns
of co-expression amongst transcripts in the network
graph. The clustered data was then exported as "class-
sets" and overlaid onto the macrophage pathway diagram
within BioLayout Express3D using the "import-class-sets"
functionality of the tool. Where genes are present in clus-
ters of co-expressed transcripts and are also present in
the pathway they can then be visualized and highlighted
on the pathway.
Additional material
Additional file 1 Integrated Map of Macrophage Pathways_graphml-
Version. This file can be opened, viewed and edited by users using the 
freely available graph-editor software yEd (yFiles software, Tubingen, Ger-
many). yEd can be downloaded at http://www.yworks.com/en/down-
loads.html#yEd where full downloading instructions are described. 
PubMed IDs supporting the interactions of the pathway are stored on 
appropriate edges and nodes within this .graphml file. Once an edge is 
selected the PubMed ID may be viewed within the descriptions tab of the 
properties box for that edge or node. Individual proteins have a url link to 
their Entrez gene entry. Furthermore some (complicated) processes also 
have additional notes to describe the events and can be found under the 
description tab of properties and when hovering over the node.
Additional file 2 List of Pathway Interactions and Supporting Publica-
tions. Interactions included in the pathway map are listed. Official HGNC 
(human gene nomenclature committee) gene symbols are used to name 
the interacting components and Entrez gene IDs are also provided. Inter-
acting components are named as individual genes/proteins and also as 
they appear on the pathway where they may be interacting as part of a 
protein complex or with a modification (e.g. Phosphorylation). Interactions 
are described as they appear on the pathway, sub-cellular location and the 
NCBI-PubMed ID for supporting literature is provided. There are also col-
umns to incorporate additional information (cell type, analytic method etc) 
where possible.
Additional file 3 Integrated Map of Macrophage Pathways_pdf-Ver-
sion. A high resolution .pdf file for viewing the integrated map of mac-
rophage pathways.
Additional file 4 Integrated Map of Macrophage Pathways_html-Ver-
sion. A high resolution flash .html version of the integrated macrophage 
pathway for viewing in a web browser.
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